BIB

Fund Description
ProShares Ultra Nasdaq Biotechnology seeks daily investment results before fees and expenses that correspond to twice (200%) the daily performance of the NASDAQ Biotechnology Index.
Fund Profile
Fund Name ProShares Ultra Nasdaq Biotechnology
Fund Exchange Ticker BIB
Fund Sponsor ProShares
Fund ISIN US74347R2141
Net Expense Ratio 0.95 %
Fund Inception Date 7 April 2010
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Leveraged / Inverse
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Nasdaq Biotech Index
Index Provider Nasdaq
Currency Hedged No
Inverse / Leveraged Leveraged (2x)
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 14 June 2019
Asset Under Management 217.94 Million (USD)
1 Month Total Return -0.90 %
Year To Date Return 10.24 %
1 Year Total Return -19.83 %
3 Year Annualized Total Return 4.02 %
NAV 46.37
Share Outstanding 4,700,000
Top 10 Holdings (14 June 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
NASDAQ Biotechnology Index SWAP Deutsche Bank AG SWAP
NASDAQ Biotechnology Index SWAP UBS AG SWAP
NASDAQ Biotechnology Index SWAP Societe Generale SWAP
iShares Biotech (IBB) SWAP Goldman Sachs International SWAP
NASDAQ Biotechnology Index SWAP Citibank NA SWAP
NASDAQ Biotechnology Index SWAP Bank of America NA SWAP
NASDAQ Biotechnology Index SWAP Goldman Sachs International SWAP
NASDAQ Biotechnology Index SWAP Credit Suisse International SWAP
NASDAQ Biotechnology Index SWAP Morgan Stanley & Co. International PLC SWAP
iShares Biotech (IBB) SWAP Bank of America NA SWAP